FactaeThe Factual News

Abivax secures financial visibility through late 2029

Abivax has announced financial visibility through the fourth quarter of 2029.

Published 2h1 sourceupdated 55m
Lire en français
≈ 14s

The fact

This forecast reassures investors about the group's stability.

The biopharmaceutical company continues its research on innovative treatments.

Click the link to read an article on the topic:
Explore this topic
What if you saw the whole news differently?Factae cross-checks hundreds of sources worldwide to keep only the fact, no opinion. Explore the front page.
France · © OpenStreetMap, OpenMapTiles, OpenFreeMapWorld map →
Follow topic →
Auto-synthesis from 1 media source · identified on September 22, 2026
← Back to home
Discover

Read more

All marches →
marches

Abivax secures financial visibility through fourth quarter 2027

17sem · 1 sourcemarches

Biotech Abivax reaches milestone after record stock market year

19sem · 1 sourcemarches800 million

Abivax raises $800 million and jumps 40% on the stock market

11sem · 1 sourcemarches920 million

Abivax raises $920 million after capital increase

11sem · 1 sourcemarches30 %

Abivax plunges on stock market after safety concerns emerge on treatment

16sem · 1 source